Skip to main content

Table 2 Effect cationic phospholipid DOTAP and DSPE-mPEG (2000) on entrapment efficiency (EE %), size and % release (R) in CUR/PTX loaded Niosomes

From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

Code

Mole Tween 60 (%)

Mole cholesterol (%)

Mole DOTAP (%)

Mole PEG (%)

EE (%)

R (%)

Size (nm)

PDI

Zeta potential (mV)

F6

64.4

27.6

0

5

EE % CUR = 91.22 ± 0.28

EE % PTX = 86.11 ± 0.66

R % CUR = 38.53 ± 0.18

R % PTX = 31.44 ± 0.16

Size CUR = 91.5 ± 0.25

Size PTX = 118.9 ± 0.31

PDI CUR = 0.179 ± 0.23

PDI PTX = 0.164 ± 0.31

Zeta CUR = − 20.99 ± 0.45

Zeta PTX = − 19.24 ± 0.44

F7

59.5

25.5

10

5

EE % CUR = 98.24 ± 0.11

EE % PTX = 98.79 ± 0.24

R % CUR = 33.11 ± 0.33

R % PTX = 20.08 ± 0.44

Size CUR = 85.4 ± 0.43

Size PTX = 111.6 ± 0.24

PDI CUR = 0.177 ± 0.17

PDI PTX = 0.158 ± 0.24

Zeta CUR = + 14.83 ± 0.21

Zeta PTX = + 16.17 ± 0.31